09/10/2025
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2025
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2025
10:28 AM | Catalyst Pharmaceuticals (Subject)
Elsbernd Brian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2025
11:19 AM | Catalyst Pharmaceuticals (Subject)
Elsbernd Brian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2025
3:30 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K/A | |
08/27/2025
3:14 PM | Catalyst Pharmaceuticals (Subject)
Tierney David S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2025
12:07 PM | Catalyst Pharmaceuticals (Subject)
Miller Steve (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2025
9:46 AM | Catalyst Pharmaceuticals (Subject)
Daly Richard J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/25/2025
3:30 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2025
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Curran Daniel J. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/04/2025
3:31 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for CPRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Catalyst Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
06/06/2025
2:42 PM | Catalyst Pharmaceuticals (Subject)
MCENANY PATRICK J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/02/2025
1:44 PM | Catalyst Pharmaceuticals (Subject)
O'Keeffe Charles B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/14/2025
9:45 AM | Catalyst Pharmaceuticals (Subject)
INGENITO GARY (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/13/2025
10:14 AM | Catalyst Pharmaceuticals (Subject)
INGENITO GARY (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/28/2025
11:32 AM | BlackRock, Inc. (Filed by)
Catalyst Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
04/14/2025
4:19 PM | Catalyst Pharmaceuticals (Filer)
| Form ARS | |
04/09/2025
7:55 AM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2025
4:00 PM | Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
3:09 PM | Catalyst Pharmaceuticals (Subject)
INGENITO GARY (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
3:21 PM | Catalyst Pharmaceuticals (Subject)
Elsbernd Brian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
9:21 AM | Catalyst Pharmaceuticals (Subject)
Del Carmen Jeffrey (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
4:40 PM | Catalyst Pharmaceuticals (Issuer)
Russo Gregg (Reporting)
| Form 3/A | |
02/26/2025
3:37 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2025
3:05 PM | Catalyst Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/13/2025
7:57 AM | Catalyst Pharmaceuticals (Subject)
Flynn James E (Filed by)
| Form SCHEDULE 13G/A | |
01/24/2025
3:30 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/21/2025
3:30 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
5:07 AM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/31/2024
3:30 PM | Catalyst Pharmaceuticals (Issuer)
Harper Molly (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:30 PM | Catalyst Pharmaceuticals (Issuer)
Sundaram Preethi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:30 PM | Catalyst Pharmaceuticals (Issuer)
Del Carmen Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:30 PM | Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:30 PM | Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:30 PM | Catalyst Pharmaceuticals (Issuer)
Daly Richard J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:30 PM | Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:30 PM | Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:30 PM | Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:30 PM | Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
4:24 PM | Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Del Carmen Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
12/11/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Sundaram Preethi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Harper Molly (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Thompson Tamar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
11:55 AM | Catalyst Pharmaceuticals (Subject)
Miller Steve (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2024
7:08 PM | Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2024
7:09 PM | Catalyst Pharmaceuticals (Issuer)
Harper Molly (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2024
7:09 PM | Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
1:42 PM | Catalyst Pharmaceuticals (Subject)
INGENITO GARY (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/27/2024
8:42 AM | Catalyst Pharmaceuticals (Subject)
Harper Molly (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024
11:37 AM | Catalyst Pharmaceuticals (Subject)
Elsbernd Brian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/25/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Elsbernd Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Thompson Tamar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Daly Richard J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
Harper Molly (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
4:01 PM | Catalyst Pharmaceuticals (Issuer)
O'Keeffe Charles B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
4:01 PM | Catalyst Pharmaceuticals (Issuer)
Kalb Michael Wayne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
4:01 PM | Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
4:01 PM | Catalyst Pharmaceuticals (Issuer)
Tierney David S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
4:01 PM | Catalyst Pharmaceuticals (Issuer)
DENKHAUS DONALD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
4:01 PM | Catalyst Pharmaceuticals (Issuer)
Miller Steve (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
4:01 PM | Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
4:01 PM | Catalyst Pharmaceuticals (Issuer)
Sundaram Preethi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
4:01 PM | Catalyst Pharmaceuticals (Issuer)
Del Carmen Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
INGENITO GARY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
4:11 PM | Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
1:57 PM | Catalyst Pharmaceuticals (Subject)
MCENANY PATRICK J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2024
4:00 PM | Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
8:55 AM | Catalyst Pharmaceuticals (Subject)
Flynn James E (Filed by)
| Form SC 13G/A | |
11/13/2024
4:44 PM | Catalyst Pharmaceuticals (Issuer)
MCENANY PATRICK J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
9:52 AM | Catalyst Pharmaceuticals (Subject)
MCENANY PATRICK J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
4:10 PM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
3:08 PM | Catalyst Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/18/2024
2:31 PM | BlackRock, Inc. (Filed by)
Catalyst Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/17/2024
11:14 AM | Catalyst Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
09/26/2024
7:42 AM | Catalyst Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
